Your session is about to expire
← Back to Search
GAMification to Encourage End-Of-Life Discussions Between ICD Patients and Caregivers (GAME-EOL Trial)
N/A
Waitlist Available
Led By Jennifer Miller, PhD
Research Sponsored by Debra Moser
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at study completion, up to 3 months post intervention
Awards & highlights
No Placebo-Only Group
Summary
This trial tests if a card game called the Hello Game can help people with heart devices (ICDs) and their families talk about end-of-life choices. The game asks thoughtful questions to encourage these important conversations. The goal is to see if playing the game helps families make better plans for end-of-life care. Card games have been used for a long time to facilitate conversations about end-of-life care, showing high satisfaction and effectiveness in discussing sensitive topics.
Eligible Conditions
- Implantable Cardioverter Defibrillator (ICD) User
- End-stage disease
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ at study completion, up to 3 months post intervention
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at study completion, up to 3 months post intervention
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Change in attitudes about discussions and actions related to end of life
Change in concordance of end of life (EOL) Attitudes
Change in experience of end of life issues
+3 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Usual care plus GAME-EOL interventionExperimental Treatment1 Intervention
Participant dyads in this group will receive usual care (standard clinical education materials) plus the GAME-EOL intervention.
Group II: Usual care recipientsActive Control1 Intervention
Participant dyads in this group will receive usual care (standard clinical education materials)
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
GAME-EOL
2021
N/A
~60
Find a Location
Who is running the clinical trial?
Debra MoserLead Sponsor
3 Previous Clinical Trials
1,085 Total Patients Enrolled
Jennifer MillerLead Sponsor
1 Previous Clinical Trials
38 Total Patients Enrolled
University of Kentucky CCTSUNKNOWN
1 Previous Clinical Trials
7 Total Patients Enrolled
Jennifer Miller, PhD4.942 ReviewsPrincipal Investigator - University of Kentucky
Medical School - University of Puerto Rico School of Medicine, Doctor of Medicine
Universidad de Puerto Rico, Residency in Obstetrics and Gynecology
5Patient Review
She was lovely, professional, and managed to put me at ease immediately. I'll definitely be returning.
Debra Moser, PhDPrincipal InvestigatorUniversity of Kentucky